Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ADNEO LIMITED Share Issue/Capital Change 2018

Oct 3, 2018

64297_rns_2018-10-03_36d3e555-c62c-4a4c-904f-a0db61eaca1b.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

APPLYDIRECT LIMITED (ASX:AD1)

ABN

29 123 129 162

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of+securities issued or to
be issued
2
Number of+securities issued or
to be issued (if known) or
maximum number which may
be issued
3
Principal terms of the+securities
(e.g. if options, exercise price
and expiry date; if partly paid
+securities,
the
amount
outstanding and due dates for
payment;
if
+convertible
securities, the conversion price
and dates for conversion)
(a) Ordinary Shares
(b)Unlisted Options
(a) 25,666,667 Ordinary Shares
(b) 8,555,547 Unlisted Options
(a) Fully Paid Ordinary Shares
(b) Unlisted Options with an exercise price
of $0.060 per Option expiring 4 October
2021
  • See chapter 19 for defined terms.

Appendix 3B Page 1

04/03/2013 ME_153853688_2

4
Do the+securities rank equally
in all respects from the+issue
date with an existing+class of
quoted+securities?
If the additional+securities do
not rank equally, please state:
• the date from which they do
• the extent to which they
participate
for
the
next
dividend, (in the case of a
trust,
distribution)
or
interest payment
• the extent to which they do
not rank equally, other than
in
relation
to
the
next
dividend,
distribution
or
interest payment
5
Issue price or consideration
6
Purpose of the issue
(If issued as consideration for
the acquisition of assets, clearly
identify those assets)
6a
Is the entity an+eligible entity
that
has
obtained
security
holder approval under rule 7.1A?
If Yes, complete sections 6b – 6h
in relation to the+securities the
subject of this Appendix 3B, and
comply with section 6i
6b
The date the security holder
resolution under rule 7.1A was
passed
6c
Number of+securities issued
without security holder approval
under rule 7.1
6d
Number of+securities issued
with security holder approval
under rule 7.1A
(a) Ordinary Shares: Yes
(b) Unlisted Options: Shares issued upon
exercise of Options will rank equally in all
respects with existing Shares.
(a) $0.030 per share
(b) Nil
(a) & (b) Private placement to investors as per
ASX release on 26 September 2018
Yes
27 November 2017
24,789,401 ordinary shares
and
8,555,547unlisted options
877,266 ordinary shares

ME_153853688_2

6e
Number of+securities issued
with security holder approval
under rule 7.3, or another
specific security holder approval
(specify date of meeting)
6f
Number of+securities issued
under an exception in rule 7.2
6g
If+securities issued under rule
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
+issue date and both values.
Include the source of the VWAP
calculation.
6h
If+securities were issued under
rule
7.1A
for
non-cash
consideration, state date on
which
valuation
of
consideration was released to
ASX Market Announcements
6i
Calculate the entity’s remaining
issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and release to ASX Market
Announcements
7
+Issue dates
Note: The issue date may be prescribed by
ASX (refer to the definition of issue date in
rule 19.12). For example, the issue date for a
pro rata entitlement issue must comply with
the applicable timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
8
Number
and
+class
of
all
+securities
quoted
on
ASX
(_including_the
+securities in
section 2 if applicable)
N/A N/A
N/A

Yes – refer to accompanying announcement
N/A
Refer to Annexure 1 below
4 October 2018
Number +Class
247,966,324 Ordinary Shares
  • See chapter 19 for defined terms.

Appendix 3B Page 3

04/03/2013 ME_153853688_2

9
Number
and
+class
of
all
+securities not quoted on ASX
(_including_the
+securities in
section 2 if applicable)
Number +Class
1,200,000
250,000
125,000
750,000
750,000
250,000
500,000
1,000,000
50,000
Options (exercisable at
$0.17 each expiring on
16 December 2018).
Options (exercisable at
$0.25 each expiring on
16 June 2019).
Options (exercisable at
$0.25 each expiring on
18 August 2019).
Options (exercisable at
$0.25 each expiring on
23 August 2019).
Options (exercisable at
$0.25 each expiring on
4 September 2019).
Options (exercisable at
$0.25 each expiring on
8 September 2019).
Options (exercisable at
$0.25 each expiring on
29 September 2019).
Options (exercisable at
$0.25 each expiring on
5 October 2019).
Options (exercisable at
$0.25 each expiring on
13 October 2019).

ME_153853688_2

9
Number
and
+class
of
all
+securities not quoted on ASX
(including the +securities in
section 2 if applicable)
1,000,000
950,000
250,000
875,000
13,879,835
4,928,119
1,625,000
15,000,000
3,405,000
3,666,667
3,666,667
3,666,666
Options (exercisable at
$0.25 each expiring on
28 November 2019).
Options (exercisable at
$0.25 each expiring on 1
December 2019).
Options (exercisable at
$0.25 each expiring on
11 December 2019).
Options (exercisable at
$0.25 each expiring on
18 December 2019).
Options (exercisable at
$0.09 each expiring on
20 December 2019).
Options (exercisable at
$0.09 each expiring on
28 January 2020).
Options (exercisable at
$0.25 each expiring on
8 March 2020).
Options (exercisable at
$0.28 each expiring on
28 April 2020).
Options (exercisable at
$0.33 each expiring on
30 April 2020).
Options (exercisable at
$0.60 each expiring on
11 September 2020).
Options (exercisable at
$0.85 each expiring on
11 September 2020).
Options (exercisable at
$1.20 each expiring on
11 September 2020).
+
0
M
See chapter 19 for defined terms.
4/03/2013
E_153853688_2
Appendix 3B Page 5
  • See chapter 19 for defined terms. 04/03/2013 ME_153853688_2

Appendix 3B Page 5

9 Number and +class of all 750,000 Options (exercisable at +securities not quoted on ASX $0.33 each expiring on (including the +securities in 28 September 2020). section 2 if applicable) Options (exercisable at 277,777 $0.09 each expiring on 19 February 2020). Options (exercisable at 8,555,547 $0.06 each expiring on 4 October 2021). Performance Rights 9,000,000

10 Dividend policy (in the case of a See page 41 of Replacement Prospectus trust, distribution policy) on the increased capital (interests)

Part 2 - Pro rata issue

11 Is security holder approval N/A required? 12 Is the issue renounceable or nonN/A renounceable? 13 Ratio in which the[+] securities N/A will be offered 14 +Class of +securities to which the N/A offer relates 15 +Record date to determine N/A entitlements 16 Will holdings on different N/A registers (or subregisters) be aggregated for calculating entitlements?

ME_153853688_2

17
Policy for deciding entitlements
in relation to fractions
18
Names of countries in which the
entity has security holders who
will not be sent new offer
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19
Closing
date
for
receipt
of
acceptances or renunciations
N/A
N/A
N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 7

04/03/2013 ME_153853688_2

20
Names of any underwriters
21
Amount of any underwriting fee
or commission
22
Names of any brokers to the
issue
23
Fee or commission payable to the
broker to the issue
24
Amount of any handling fee
payable to brokers who lodge
acceptances or renunciations on
behalf of security holders
25
If the issue is contingent on
security holders’ approval, the
date of the meeting
26
Date entitlement and acceptance
form and offer documents will be
sent to persons entitled
27
If the entity has issued options,
and the terms entitle option
holders
to
participate
on
exercise, the date on which
notices will be sent to option
holders
28
Date rights trading will begin (if
applicable)
29
Date rights trading will end (if
applicable)
30
How do security holders sell
their entitlements_in full_through
a broker?
31
How do security holders sell_part_
of their entitlements through a
broker
and
accept
for
the
balance?
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 8 ME_153853688_2

04/03/2013

  • 32 How do security holders dispose N/A of their entitlements (except by sale through a broker)?

  • 33 +Issue date N/A

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of[+] securities ( tick one )

  • (a)  +Securities described in Part 1 (Ordinary Shares Only)

  • (b)[All other ][+][securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

  • 35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

  • 36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 - 1,000

1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

  • 37 A copy of any trust deed for the additional[+] securities
  • See chapter 19 for defined terms.

Appendix 3B Page 9

04/03/2013 ME_153853688_2

Entities that have ticked box 34(b)

38 Number of[+] securities for which N/A +quotation is sought 39 +Class of +securities for which N/A quotation is sought 40 Do the[+] securities rank equally in N/A all respects from the[+] issue date with an existing[+] class of quoted +securities? If the additional[+] securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 41 Reason for request for quotation N/A now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another[+] security, clearly identify that other[+] security) Number +Class 42 Number and +class of all N/A N/A +securities quoted on ASX ( including the[+] securities in clause 38)

  • See chapter 19 for defined terms. Appendix 3B Page 10 ME_153853688_2

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted +quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

==> picture [95 x 33] intentionally omitted <==

Sign here: ............................................................ (Company secretary)

Date: 4 October 2018

Print name: Prashant Chandra

  • See chapter 19 for defined terms.

Appendix 3B Page 11

ME_153853688_2

== == == == ==

  • See chapter 19 for defined terms.

Appendix 3B Page 12 ME_153853688_2

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

==> picture [415 x 403] intentionally omitted <==

----- Start of picture text -----

Insert number of fully paid [+] ordinary 171,463,135
securities on issue 12 months before the
+ issue date or date of agreement to issue
Add the following: 50,836,522
• Number of fully paid [+] ordinary securities
issued in that 12 month period under an
exception in rule 7.2
• Number of fully paid [+] ordinary securities
issued in that 12 month period with
shareholder approval
• Number of partly paid [+] ordinary
securities that became fully paid in that
12 month period
Note:
• Include only ordinary securities here –
other classes of equity securities cannot
be added
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
Subtract the number of fully paid [+] ordinary -
securities cancelled during that 12 month
period
“A” 222,299,657
----- End of picture text -----

  • See chapter 19 for defined terms.

Appendix 3B Page 13

ME_153853688_2

Step 2: Calculate 15% of “A”

“B” 0.15 [Note: this value cannot be changed] Multiply “A” by 0.15 33,344,949

Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been used

Insert number of[+] equity securities issued 33,344,948 or agreed to be issued in that 12 month period not counting those issued:

  • Under an exception in rule 7.2

  • Under rule 7.1A

  • With security holder approval under rule 7.1 or rule 7.4

Note:

  • This applies to equity securities, unless specifically excluded – not just ordinary securities

  • • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

  • It may be useful to set out issues of securities on different dates as separate line items

  • “C” 33,344,948

Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1

placement capacity under rule 7.1
“A” x 0.15 33,344,949
Note: number must be same as shown in
Step 2
Subtract“C” 33,344,948
Note: number must be same as shown in
Step 3
Total[“A” x 0.15] – “C” 1
[Note: this is the remaining placement
capacity under rule 7.1]
  • See chapter 19 for defined terms.

Appendix 3B Page 14 ME_153853688_2

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

“A” 222,299,657 Note: number must be same as shown in Step 1 of Part 1 Step 2: Calculate 10% of “A” “D” 0.10 Note: this value cannot be changed Multiply “A” by 0.10 22,229,966

Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

  • Insert number of[+] equity securities issued 877,266 or agreed to be issued in that 12 month period under rule 7.1A Notes: • This applies to equity securities – not just ordinary securities

  • • Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed

  • • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

  • • It may be useful to set out issues of securities on different dates as separate line items

  • “E” 877,266

  • See chapter 19 for defined terms.

Appendix 3B Page 15

ME_153853688_2

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
“A” x 0.10
Note: number must be same as shown in
Step 2
22,229,966
Subtract“E”
Note: number must be same as shown in
Step 3
877,266
Total[“A” x 0.10] – “E” 21,352,700
Note: this is the remaining placement
capacity under rule 7.1A
  • See chapter 19 for defined terms.

Appendix 3B Page 16 ME_153853688_2

==> picture [159 x 30] intentionally omitted <==

4 October 2018

ASX ANNOUNCEMENT

ApplyDirect Limited ACN 123 129 162 ( Company )

Notice Under Section 708A(5) of the Corporations Act

[ASX Code: AD1]

This notice is given under paragraph (5)(e) of section 708A of the Corporations Act.

Type: Shares
Class/Description: Ordinary
ASX Code: AD1
Date of Issue: 4 October 2018
Number Issued: 25,666,667
Issue Price per Security: $0.030

Accordingly, the Company gives notice under section 708A(5)(e) of the Corporations Act 2001 (Cth)

( Corporations Act ) that:

  1. the ordinary shares set out above were issued to sophisticated and professional investors without disclosure under Part 6D.2 of the Corporations Act ;

  2. as at the date of this notice the Company has complied with:

  3. (i) the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and

  4. (ii) section 674 of the Corporations Act; and

  5. as at the date of this notice there is no "excluded information" (as defined in subsection 708A(7) of the Corporations Act) which is required to be disclosed by the Company.

For and on behalf of the Company,

==> picture [85 x 31] intentionally omitted <==

Prashant Chandra

Company Secretary

ME_153855730_1